Newsroom | 6999 results
Sorted by: Latest
-
Quantum Motion Raises $160 Million Series C to Deliver Quantum Computing’s “Transistor Moment”
LONDON--(BUSINESS WIRE)--Quantum Motion, the leading company in silicon transistor-based quantum computing, today announced a $160 million Series C round to commercialise its scalable and energy-efficient approach to quantum computing. The round is co-led by DCVC and Kembara, with participation from new investors, the British Business Bank and Firgun, alongside existing investors. The financing positions Quantum Motion to deliver utility-scale and commercially viable quantum computers that fit...
-
NVE Corporation Reports Fourth Quarter and Fiscal Year Results and Announces Quarterly Dividend
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NVE Corporation (Nasdaq: NVEC) announced today financial results for the quarter and fiscal year ended March 31, 2026. Total revenue for the fourth quarter of fiscal 2026 increased 5% to $7.65 million from $7.27 million for the prior-year quarter. The increase was due to a 6% increase in product sales, partially offset by a 19% decrease in contract research and development revenue. Net income for the fourth quarter of fiscal 2026 increased 27% to $4.93 mill...
-
Amprius Technologies Reports First Quarter 2026 Financial Results and Recent Business Highlights
FREMONT, Calif.--(BUSINESS WIRE)--Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE: AMPX), a leader in silicon anode lithium-ion batteries, today announced financial results for the first quarter ended March 31, 2026, and discussed recent business developments. Revenue for the first quarter of 2026 was $28.5 million, up 2.5x from $11.3 million in the first quarter of 2025. Net loss was $5.0 million, compared to a net loss of $9.4 million in the first quarter of 2025. Net loss per s...
-
Bruker Reports First Quarter 2026 Financial Results
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three months ended March 31, 2026. Frank H. Laukien, Bruker’s President and CEO, commented: “While US academic demand, tariff and currency headwinds still pressured our first quarter results, our Q1 financial performance came in ahead of expectations. We are encouraged that our first quarter BSI segment bookings grew organically at a high single digit percentage, and our BSI book-to-bi...
-
Wolfspeed Reports Financial Results for the Third Quarter of Fiscal 2026
DURHAM, N.C.--(BUSINESS WIRE)--Wolfspeed, Inc. (NYSE: WOLF) today announced its results for the third quarter of fiscal 2026. Business Highlights Continued sequential quarterly growth in AI data center applications of approximately 30%, reflecting a moderate but expanding part of the Company's business with meaningful long-term potential. Launched first commercially available 10 kV SiC power MOSFET for grid modernization, industrial electrification and AI data center infrastructure. Introduced...
-
Onto Innovation Reports 2026 First Quarter Results
WILMINGTON, Mass.--(BUSINESS WIRE)--Onto Innovation Inc. (NYSE: ONTO) (“Onto Innovation,” “Onto,” or the “Company”) today announced financial results for the first quarter of 2026. First Quarter Business and Financial Highlights: Record quarterly revenue of $292 million, representing nearly 10% sequential growth from the fourth quarter of 2025. Dragonfly® G5 system qualified at a leading 2.5D logic customer and a high-bandwidth memory customer, establishing a new level of performance and flexib...
-
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 115,279 equity awards, consisting of 101,931 restricted stock units (“RSUs”) and up to 13,348 performance stock units (“PSUs”), will be granted to 53 recently hired individuals, in each case as an inducement material to their acceptance of employment w...
-
Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the first quarter ended March 31, 2026, and provided a business update. “During the first quarter, we continued to execute on our two clinical stage in vivo gene editing programs. We advanced PBGENE-HBV into new cohorts in the EL...
-
Universal Display Corporation Announces Participation at Upcoming Conferences
EWING, N.J.--(BUSINESS WIRE)--UDC announced its participation in investor and industry conferences taking place in May, June and July 2026....
-
30 TD SYNNEX Leaders Recognized as 2026 CRN® Women of the Channel
FREMONT, Calif. & CLEARWATER, Fla.--(BUSINESS WIRE)--TD SYNNEX (NYSE:SNX), a leading global distributor and solutions aggregator for the IT ecosystem, today announced that CRN®, a brand of The Channel Company, has named 30 TD SYNNEX leaders to the prestigious Women of the Channel list for 2026. This annual CRN list celebrates women from vendors, distributors, solution providers and other channel-focused organizations who make a positive difference in the IT ecosystem. The CRN 2026 Women of the...